Recruiting NCT07136467
A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Non-Segmental Vitiligo (NSV), Alopecia Areata, Hidradenitis Suppurativa. Basic parameters: from 12 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Argentina, Canada, Colombia, Czechia, Estonia +13
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Multi-Country, Cross-sectional Study to Characterize Real World Burden of Disease in Adolescent and Adult Patients With Alopecia Areata, Vitiligo or Hidradenitis Suppurativa (MEASURE AAVitHS)
Overview
This study is to assess the burden of disease in adolescent and adult participants with moderate or severe alopecia areata (AA), non-segmental vitiligo (NSV), or moderate to severe hidradenitis suppurativa (HS) in a large global real-world participant population.
Primary outcome measures
- Alopecia Areata (AA) symptoms affecting quality of life and daily functioning, assessed by the Alopecia Areata Symptom Impact Scale (AASIS) AA only [Time frame: Up to Day 1]
- Measuring scalp hair loss, assessed by the Severity of Alopecia Tool (SALT) score. AA only [Time frame: Up to Day 1]
- Measuring facial skin depigmentation, assessed by the Facial Vitiligo Area Scoring Index (F-VASI) Vitiligo Only [Time frame: Up to Day 1]
- Vitiligo Quality of Life (QOL), assessed by Vitiligo Quality of Life Score (VitiQoL) Vitiligo Only [Time frame: Up to Day 1]
- Hidradenitis Suppurativa (HS) Quality of Life (QOL), assessed by Dermatology Life Quality Index (DLQI)/Children's Dermatology Life Quality Index (CDLQI) HS only [Time frame: Up to Day 1]
- Measuring disease severity, assessed by the International Hidradenitis Suppurativa Severity Scoring System (IHS4) HS only [Time frame: Up to Day 1]
Eligibility criteria
Inclusion criteria
- Participants with Physician-confirmed diagnosis of non-segmental vitiligo (NSV), moderate to severe Alopecia Areata (AA), or moderate to severe hidradenitis suppurativa (HS)
- Participants Ability to understand study questionnaires, with caregiver support as required for adolescents
Exclusion criteria
- Participating in interventional clinical trial(s) at time of study visit (participation in another non-interventional study or registry does not exclude a participant from this study)
- Unable or unwilling to comply with study requirements and PRO collection
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-only
Study locations
France · 22 centers
- Chu Dijon /Id# 277493 — Dijon
- Centre Hospitalier Regional Universitaire de Besancon - Hopital Jean Minjoz /ID# 277459 — Besançon
- Centre Hospitalier Universitaire de Bordeaux - Groupe Hospitalier Saint-Andre /ID# 277322 — Bordeaux
- CHU Toulouse - Hopital Larrey /ID# 277321 — Toulouse
- CHU Rennes - Hôpital PONTCHAILLOU /ID# 277527 — Rennes
- Centre Hospitalier Régional Universitaire De Tours - Hôpital Trousseau /ID# 277545 — Chambray-lès-Tours
- CHU Grenoble - Hopital Michallon /ID# 277501 — La Tronche
- Centre Hospitalier de Bretagne Sud /ID# 277559 — Lorient
- … and 14 more centers
Germany · 21 centers
- Mvz Corius Biberach Gmbh /Id# 281157 — Biberach an der Riss
- Derma Sana /ID# 279254 — Karlsruhe
- Private Practice - Dr. Virgil Oreste Mihaescu /ID# 279229 — Augsburg
- Hautarztpraxis Hassberge Dr. Boris Bauer /ID# 279272 — Haßfurt
- Dr. Neumann /ID# 279255 — Kelheim
- Dermakulm /Id# 279126 — Kulmbach
- Studienzentrum an der Hase GbR Dr. Weyergraf/Dr. Frick/Thomas Heiber /ID# 279210 — Bramsche
- Hautarztliche Gemeinschaftspraxis Dres. med. Petri & Mocklinghoff /ID# 279230 — Ahaus
- … and 13 more centers
Switzerland · 10 centers
Center list to be confirmed — check the primary protocol.
Canada · 9 centers
- Dermatology Research Institute - Blackfoot Trail /ID# 276548 — Calgary
- Rejuvenation Dermatology - Edmonton Downtown /ID# 276593 — Edmonton
- Alberta Dermatology Consultants /ID# 277187 — Edmonton
- Brunswick Dermatology Center /ID# 276546 — Fredericton
- Simcoderm Medical And Surgical Dermatology Centre /ID# 276838 — Barrie
- DermEffects /ID# 276594 — London
- Lynderm Research Inc /ID# 276595 — Markham
- York Dermatology Clinic & Research Centre /ID# 276697 — Richmond Hill
- … and 1 more center
United Kingdom · 8 centers
Center list to be confirmed — check the primary protocol.
Romania · 7 centers
Center list to be confirmed — check the primary protocol.
Greece · 6 centers
- University General Hospital Attikon /ID# 278395 — Athens
- General Hospital Andreas Syggros /ID# 276969 — Athens
- Tzaneio Prefecture General Hospital of Piraeus /ID# 276881 — Piraeus
- The University Hospital of Larissa /ID# 277234 — Larissa
- Hospital of Skin and Venereal Diseases- Thessaloniki /ID# 277278 — Thessaloniki
- Papageorgiou General Hospital /ID# 277450 — Thessaloniki
Spain · 6 centers
Center list to be confirmed — check the primary protocol.
Argentina · 5 centers
- Hospital Britanico de Buenos Aires /ID# 278940 — Ciudad Autonoma de Buenos Aire
- Buenos Aires Skin /ID# 277637 — Buenos Aires
- Centro de Investigacion y Prevencion Cardiovascular (CIPREC) /ID# 277634 — Buenos Aires
- Hospital Italiano de Buenos Aires /ID# 277636 — Buenos Aires
- Instituto de Neumonología y Dermatología /ID# 277635 — Buenos Aires
Japan · 4 centers
- Nagomi Dermatology Clinic /ID# 279997 — Ebina-shi
- Shinsaibashi Inui Dermatology Clinic /ID# 280564 — Osaka
- Inokashira Park Skin Clinic /ID# 279276 — Mitaka-shi
- Omori Ekimae Dermatology Clinic /ID# 279277 — Ōta-ku
Czechia · 3 centers
- Nemocnice Na Bulovce /ID# 275542 — Prague
- Dermafit Centrum /ID# 275863 — Pilsen
- Dermamedest /ID# 275861 — Prague
Italy · 3 centers
- Azienda Ospedaliero-Universitaria di Ferrara - Arcispedale S.Anna /ID# 276986 — Cona
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Universita Cattolica /ID# 2777 — Rome
- A.O.U. Consorziale Policlinico di Bari /ID# 276857 — Bari
Puerto Rico · 3 centers
- Dermatologia Borinquen LLC /ID# 276802 — Caguas
- Dr. Samuel Sanchez PSC /ID# 276386 — Caguas
- … and 1 more center
Colombia · 2 centers
- Centro de Inmunología y Genética CIGE SAS /ID# 280793 — Medellín
- Policlinico Social Del Norte /ID# 280935 — Bogotá
Estonia · 2 centers
- North Estonia Medical Centre /ID# 276933 — Tallinn
- Tartu University Hospital /ID# 276932 — Tartu
South Korea · 2 centers
Center list to be confirmed — check the primary protocol.
Taiwan · 2 centers
Center list to be confirmed — check the primary protocol.
Latvia · 1 center
- Riga 1st Hospital /ID# 276361 — Riga
Identifiers
NCT: NCT07136467 · H25-663